These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2448024)

  • 21. Highly enhanced fucosylation of alpha-fetoprotein in patients with germ cell tumor.
    Aoyagi Y; Suzuki Y; Igarashi K; Yokota T; Mori S; Suda T; Naitoh A; Isemura M; Asakura H
    Cancer; 1993 Jul; 72(2):615-8. PubMed ID: 7686444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma (HCC) and diagnostic significance of A-fetoprotein (AFP).
    Baig JA; Alam JM; Mahmood SR; Baig M; Shaheen R; Sultana I; Waheed A
    J Ayub Med Coll Abbottabad; 2009; 21(1):72-5. PubMed ID: 20364746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
    Na K; Jeong SK; Lee MJ; Cho SY; Kim SA; Lee MJ; Song SY; Kim H; Kim KS; Lee HW; Paik YK
    Int J Cancer; 2013 Jul; 133(2):408-15. PubMed ID: 23319432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
    PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas.
    Yamashita K; Taketa K; Nishi S; Fukushima K; Ohkura T
    Cancer Res; 1993 Jul; 53(13):2970-5. PubMed ID: 7686446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.
    Oda K; Ido A; Tamai T; Matsushita M; Kumagai K; Mawatari S; Saishoji A; Kure T; Ohno K; Toyokura E; Imanaka D; Moriuchi A; Uto H; Oketani M; Hashiguchi T; Tsubouchi H
    Oncol Rep; 2011 Nov; 26(5):1227-33. PubMed ID: 21874252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation.
    Kim KH; Lee SY; Hwang H; Lee JY; Ji ES; An HJ; Kim JY; Yoo JS
    Proteomics Clin Appl; 2018 Nov; 12(6):e1800062. PubMed ID: 29888876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary transforming growth factor-beta 1 in relation to serum alpha-fetoprotein in hepatocellular carcinoma.
    Tsai JF; Jeng JE; Chuang LY; Chang WY; Hsieh MY; Lin ZY; Tsai JH
    Scand J Gastroenterol; 1997 Mar; 32(3):254-60. PubMed ID: 9085463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic significance of estimation of serum apolipoprotein A along with alpha-fetoprotein in alcoholic cirrhosis and hepatocellular carcinoma patients.
    Nayak SS; Kamath SS; Kundaje GN; Aroor AR
    Clin Chim Acta; 1988 Apr; 173(2):157-64. PubMed ID: 2454172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
    Farinati F; Marino D; De Giorgio M; Baldan A; Cantarini M; Cursaro C; Rapaccini G; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M; Trevisani F
    Am J Gastroenterol; 2006 Mar; 101(3):524-32. PubMed ID: 16542289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of alpha 1-fetoprotein (AFP) determination with an ultramicro-ELISA immunoassay in chronic liver diseases with special reference to hepatocellular cancer].
    Reinhardt M; Schulze M; Machnik G; Jorke D; Laske V; Krombholz B; Kappauf G; Schröder S
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(5):230-41. PubMed ID: 2449324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea.
    Ahn DG; Kim HJ; Kang H; Lee HW; Bae SH; Lee JH; Paik YH; Lee JS
    Korean J Intern Med; 2016 Jan; 31(1):46-53. PubMed ID: 26767857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fucosylated fraction of alpha-fetoprotein as a serological marker of early hepatocellular carcinoma.
    Moriya S; Morimoto M; Numata K; Nozaki A; Shimoyama Y; Kondo M; Nakano M; Maeda S; Tanaka K
    Anticancer Res; 2013 Mar; 33(3):997-1001. PubMed ID: 23482772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma.
    Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Takasaki K; Takenami K; Yamamoto M; Nakano M
    Cancer; 2000 Feb; 88(3):544-9. PubMed ID: 10649245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
    Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
    Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical application of determining serum AFP-IgM complexes for diagnosis of small hepatocellular carcinoma.
    Jiang J; Wu C; Shen Y; Xu B; Zheng X; Li X; Xu N
    Anticancer Res; 2011 Feb; 31(2):687-91. PubMed ID: 21378357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.
    Dai M; Chen X; Liu X; Peng Z; Meng J; Dai S
    PLoS One; 2015; 10(10):e0140067. PubMed ID: 26441340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of tumor markers for the detection of hepatocellular carcinoma in Yangon General Hospital, Myanmar.
    Taketa K; Okada S; Win N; Hlaing NK; Wind KM
    Acta Med Okayama; 2002 Dec; 56(6):317-20. PubMed ID: 12685861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
    Yao M; Zhao J; Lu F
    Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.